We are live on
!
Find out more
3C
361 Capital Portfolio holdings
AUM
$213M
1-Year Est. Return
24.26%
This Fund
S&P 500
This Quarter
Est. Return
-20.52%
1 Year Est. Return
+24.26%
3 Year Est. Return
+117.64%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$220M
AUM Growth
-$141M
(-39%)
Cap. Flow
-$75.9M
Cap. Flow
% of AUM
-34.5%
Top 10 Holdings %
Top 10 Hldgs %
7.96%
Holding
421
New
120
Increased
25
Reduced
138
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Williams Companies
WMB
|
+$1.94M |
| 2 |
BERY
Berry Global Group, Inc.
BERY
|
+$1.81M |
| 3 |
TransUnion
TRU
|
+$1.79M |
| 4 |
RenaissanceRe
RNR
|
+$1.76M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$1.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$2.21M |
| 2 |
PACCAR
PCAR
|
+$2.16M |
| 3 |
Spotify
SPOT
|
+$2.12M |
| 4 |
US Foods
USFD
|
+$2.06M |
| 5 |
ONE Gas
OGS
|
+$1.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.83% |
| 2 | Healthcare | 15.4% |
| 3 | Industrials | 12.81% |
| 4 | Financials | 12.39% |
| 5 | Real Estate | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Western Digital
WDC
$188B
| $259K | 0.12% |
+8,228
| New | +$364K |
|
277
Vanguard FTSE Emerging Markets ETF
VWO
$121B
| $239K | 0.11% |
7,114
-5,231
| -42% | -$213K |
|
278
Bristol-Myers Squibb
BMY
$133B
| $221K | 0.1% |
+3,966
| New | +$242K |
|
279
Bank of America
BAC
$435B
| $219K | 0.1% |
+10,299
| New | +$309K |
|
280
M&T Bank
MTB
$35.7B
| $219K | 0.1% |
+2,115
| New | +$311K |
|
281
nVent Electric
NVT
$24.9B
| $212K | 0.1% |
+12,560
| New | +$293K |
|
282
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.76B
| $206K | 0.09% |
5,854
-1,826
| -24% | -$88K |
|
283
Schwab Fundamental US Small Company Index ETF
FNDA
$9.12B
| $204K | 0.09% |
15,748
-8,166
| -34% | -$145K |
|
|
GAP
284
The Gap Inc
GAP
$7.23B
| $164K | 0.07% |
+23,297
| New | +$346K |
|
285
Halliburton
HAL
$26.9B
| $114K | 0.05% |
+16,682
| New | +$290K |
|
286
Acadia Pharmaceuticals
ACAD
$4.43B
| – | – |
-29,686
| Closed | -$1.27M |
|
287
Arch Capital
ACGL
$34.3B
| – | – |
-12,234
| Closed | -$525K |
|
288
Allegiant Air
ALGT
$2.64B
| – | – |
-7,299
| Closed | -$1.27M |
|
289
Ametek
AME
$55.4B
| – | – |
-18,168
| Closed | -$1.81M |
|
290
Ameriprise Financial
AMP
$48.3B
| – | – |
-3,312
| Closed | -$552K |
|
291
Anika Therapeutics
ANIK
$258M
| – | – |
-23,509
| Closed | -$1.22M |
|
292
AeroVironment
AVAV
$7.56B
| – | – |
-20,716
| Closed | -$1.28M |
|
293
Avantor
AVTR
$9.32B
| – | – |
-12,707
| Closed | -$231K |
|
294
AZZ Inc
AZZ
$4.35B
| – | – |
-27,236
| Closed | -$1.25M |
|
295
Benchmark Electronics
BHE
$2.87B
| – | – |
-38,153
| Closed | -$1.31M |
|
296
Badger Meter
BMI
$3.89B
| – | – |
-21,218
| Closed | -$1.38M |
|
297
Citigroup
C
$222B
| – | – |
-11,582
| Closed | -$925K |
|
|
CADE
298
DELISTED
Cadence Bank
CADE
| – | – |
-40,925
| Closed | -$1.28M |
|
299
CarGurus
CARG
$3.27B
| – | – |
-32,551
| Closed | -$1.15M |
|
300
CDW
CDW
$18.9B
| – | – |
-8,415
| Closed | -$1.2M |
|
Similar funds
SIA
PV
RCM
ALIA
TL
RI
SMFS
HF
361 Capital's Q1 2020 Portfolio in Review
As of Q1 2020, 361 Capital held 421 positions worth $220M, down 39% from $361M the previous quarter. Its ten largest holdings account for 8% of the portfolio.
361 Capital withdrew a net $75.9M in Q1 2020, closing 136 positions and reducing 138 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $2.21M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, 361 Capital opened a new position in Williams Companies worth $1.42M.
- 361 Capital's largest Q1 2020 buy was Williams Companies: 100,317 shares worth $1.42M.
- 361 Capital added most to Huntington Ingalls Industries in Q1 2020, an estimated $1.2M increase.
- 361 Capital's biggest Q1 2020 reduction was Zebra Technologies, cutting an estimated $1.52M.
- 361 Capital fully exited Jazz Pharmaceuticals in Q1 2020, selling an estimated $2.21M.
- 361 Capital's ten largest holdings make up 8% of its $220M portfolio in Q1 2020.
- 361 Capital opened 120 new positions and closed 136 in Q1 2020.
- 361 Capital's portfolio value fell 39% quarter-over-quarter to $220M.
Based on 361 Capital's 13F filing for Q1 2020, filed 13 May 2020.